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Abstract
Background: Gene synthesis technologies are an important tool for structural biology projects,
allowing increased protein expression through codon optimization and facilitating sequence
alterations. Existing methods, however, can be complex and not always reproducible, prompting
researchers to use commercial suppliers rather than synthesize genes themselves.
Results: A PCR-based gene synthesis method, referred to as SeqTBIO, is described to efficiently
assemble the coding regions of two novel hyperthermophilic proteins, PAZ (Piwi/Argonaute/
Zwille) domain, a siRNA-binding domain of an Argonaute protein homologue and a deletion mutant
of a family A DNA polymerase (PolA). The gene synthesis procedure is based on sequential
assembly such that homogeneous DNA products can be obtained after each synthesis step without
extensive manipulation or purification requirements. Coupling the gene synthesis procedure to in
vivo  homologous recombination techniques allows efficient subcloning and site-directed
mutagenesis for error correction. The recombinant proteins of PAZ and PolA were subsequently
overexpressed in E. coli and used for protein crystallization. Crystals of both proteins were
obtained and they were suitable for X-ray analysis.
Conclusion: We demonstrate, by using PAZ and PolA as examples, the feasibility of integrating
the gene synthesis, error correction and subcloning techniques into a non-automated gene to
crystal pipeline such that genes can be designed, synthesized and implemented for recombinant
expression and protein crystallization.
Background
Gene synthesis is a convenient method of obtaining
sequence-verified cloned DNA, especially when the source
biological material is not readily available (rare, lost or
dangerous specimens), when codons need to be opti-
mized for expression in a particular host or when the
desired sequence is chimeric or designed de novo. In a gene
to structure pipeline utilizing X-ray crystallography, cus-
tomizing the synthesis of the open reading frame to rap-
idly express recombinant protein for crystallization
becomes particularly useful in structure determination
endeavors. This is particularly the case when specific resi-
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dues within a certain site or entire regions of a protein
need to be altered to change protein activity, stability or
ability to crystallize.
Structural genomics consortia have exploited gene synthe-
sis technology to produce difficult recombinant proteins
for structural analysis [1]. In most cases, if not all, syn-
thetic genes are fabricated commercially for convenience
and time efficiency. Presently, the affordability of syn-
thetic oligonucleotides (the building blocks for gene syn-
thesis) makes it possible for individual researchers to carry
out their own gene synthesis projects in their home labo-
ratories if gene synthesis procedures can be streamlined
and performed without intricate manipulations. In addi-
tion, combining feasible gene synthesis techniques with
quick cloning methods into recombinant expression sys-
tems without extensive enzymatic requirements would
also greatly facilitate protein structure investigations.
In this study, we use a PCR-based gene synthesis tech-
nique coupled to in vivo homologous recombination to
quickly construct genes for protein production without
the use of any additional enzyme. The coding sequences
of two proteins derived from hyperthermophilic microor-
ganisms have been synthesized and transformed with a
specially prepared expression vector into a bacterial
expression system without DNA digestion or ligation.
Recombinant proteins were overexpressed from the syn-
thetic gene constructs, purified and used for protein crys-
tallization. Using this method, the entire procedure from
gene to crystal screening can be performed within 2
weeks. The procedure described here would especially
benefit small traditional structural biology laboratories as
the technique to synthesize DNA coding sequences for
direct protein production requires no automation and can
be executed without great cost and time consumption.
Methods
Source of DNA sequences
The nucleotide coding regions of a PAZ (Piwi/Argonaute/
Zwille) domain and a deletion mutant (lacking the 5'-3'
exonuclease domain) of a family A DNA polymerase
(PolA) were selected for synthesis. The sequences of the
synthesized genes were derived from the genetic material
of two hyperthermophilic microorganisms isolated from
mud samples collected at the Rainbow hydrothermal vent
field on the North-Atlantic Ridge: the sulfur-reducing
archaeon Thermococcus thioreducens [2] and an uncharac-
terized bacterium designated OGL-7B (unpublished). The
latter was isolated as a single colony from a 90°C culture
of an autoclaved mud sample and could not be cultured
further. The PAZ domain and PolA nucleotide sequences,
hereafter designated as paz and polA, were derived from
Thermococcus thioreducens and OGL-7B respectively.
Preparation of linearized vector
About 5 μg of pET3a plasmid (Novagen, Madison, USA)
was double digested with NdeI and BamH1 restriction
endonucleases (Promega, Madison, WI, USA) following
the manufacturer's instructions. The digested plasmid was
purified using the QIAquick PCR purification kit (Qiagen,
Valencia, CA, USA), blunt-ended with Klenow fragment
(Promega, Madison, WI, USA) according to the manufac-
turer's directions and further purified as described above.
The resulting pET3a fragment was used for homologous
recombination reactions without further modification.
Design of oligonucleotides for gene synthesis
Oligonucleotides for gene synthesis were designed using
DNAWorks [3,4] with the following parameters: E. coli
class II codon frequency table, 60°C annealing tempera-
ture, 60 (for polA) and 75 (for paz) nt oligonucleotide
length, 5 solutions and TBIO mode. Default values were
kept for other parameters. For each gene, the input
sequence consisted of 3 elements: 30 nt of the pET3a
(Novagen, Madison, USA) vector sequence upstream of
the NdeI site, followed by the amino acid sequence corre-
sponding to the gene to be synthesized, and finally 30 nt
of the pET3a vector sequence downstream of the BamHI
site. Solutions with the lowest scores were selected for syn-
thesis. Oligonucleotides were synthesized by Operon
(Huntsville, AL, USA) and diluted to a working concentra-
tion of 2 μM. Oligonucleotide sequences for polA and paz
are shown in Tables 1 and 2 respectively.
Gene synthesis
Each gene was assembled through a sequence of n reac-
tions, where n is half the number of oligonucleotides
used. Only 2 oligonucleotides were added to each reac-
tion, starting with the central pair (f1 and r1), followed by
the next pairs (f2 and r2, then f3 and r3, etc.) in the subse-
quent reactions, in an inside-out manner (Figure 1A). A
total of 4 and 22 primer pairs were used for the synthesis
of paz and polA respectively. Each reaction took place in a
12 μl volume and included Pfu Ultra II Fusion HS DNA
polymerase (Stratagene, La Jolla, CA, USA) and its corre-
sponding buffer according to the manufacturer's instruc-
tions, dNTP at a final concentration of 200 μM each, 0.9
ul of each oligonucleotide and 0.9 μl of the previous reac-
tion product (0.9 μl distilled water instead in the first reac-
tion). All PCR were performed in a Perkin Elmer
GeneAmp PCR System 9600 thermal cycler. Each reaction
was subjected to 7 cycles of 95°C denaturation for 15 s,
55°C annealing for 20 s and 72°C extension for 20 s.
Extension time was increased to 30 s after the 12th reaction
and to 40 s after the 30th. Five μl of the last reaction were
mixed with 50 ng of linearized pET3a and used for trans-
formation.BMC Biotechnology 2008, 8:44 http://www.biomedcentral.com/1472-6750/8/44
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Transformation and sequence analysis
E. coli strain DH5α was rendered competent using the
rubidium chloride method [5]. DNA mixtures were gently
mixed with 50 μl competent cells. After 15 min incuba-
tion on ice, cells were heat-shocked at 42°C for 80 s.
Thereafter, the transformed cells were diluted with 150 μl
Luria-Bertani (LB) medium, incubated 1 hour at 37°C/
250 RPM and spread on LB-agar plates containing 100
mg/L carbenicillin. Colonies were visible after 16 hours
incubation at 37°C. Colonies were picked without screen-
ing and grown in 5–10 ml LB complemented with 100
mg/L carbenicillin at 37°C/250 RPM for 12–16 hours.
Plasmids were purified using EZNA plasmid Miniprep kit
II (Omega Bio-Tek, Doraville, GA, USA). Sequencing was
performed by Functional Biosciences (Madison, WI, USA)
using vector-specific sequencing primers flanking the
Table 1: Oligonucleotides for the synthesis of polA
f22 TTTGTTTAACTTTAAGAAGGAGATATACATATGCTCCGCAAGG
f21 ATATACATATGCTCCGCAAGGTCGAGGTACAAACCGTAGAGCCGGAGGACCGTGAAAGCT
f20 GGAGGACCGTGAAAGCTGGAACGACTTCCTGGAAAATCCACTCCTCAGCCTGTGGCTCGA
f19 TCAGCCTGTGGCTCGAGATGGACGGCGAAAACTATCATCGCGCAGAAATCATCGGTCTCG
f18 GCAGAAATCATCGGTCTCGCACTGTCTGATGGTGAGACCCATCTGTACGTCCCTTGGCGC
f17 GTACGTCCCTTGGCGCACTGCGCGTGACTGGGAGAACCTCCACCGTCTGCTCGCGGACGA
f16 TCTGCTCGCGGACGAGGAACGCAAGAAGATTGTTTATGATGGTAAACGTCTGCAAGTGGT
f15 GTAAACGTCTGCAAGTGGTGCTGAAGCGTCGTGGTCTGGAGGCTGGCGGTCTGGCTTTCG
f14 GGCGGTCTGGCTTTCGACGCGCTCCTGGCTTCTTATCTGCTGGACCCGTCCGAATCTGGC
f13 CCCGTCCGAATCTGGCCACTCTCTGTCCGACCTGGTACAGCGTAAGATGGATGGCTCTCT
f12 CGTAAGATGGATGGCTCTCTCCCACCTGATGAGGAGGTTTACGGTAAAGGTGCCAAACGC
f11 GGTAAAGGTGCCAAACGCCGCCTGCCAGGTGAGCGCGAACTCGCTGAACATCTCGCGCGT
f10 CTGAACATCTCGCGCGTAAAGCGGAAGCGCTCAAGCGCCTCTACCCACTGCTGAGCGAGG
f9 CCACTGCTGAGCGAGGAGATCCGTGAGGCCGGTATGGAGAGCCTGCTCTTTGAAATGGAA
f8 GCCTGCTCTTTGAAATGGAACTGCCACTGAGCCGTGTTCTGGCAGAGATGGAGCTGCATG
f7 CAGAGATGGAGCTGCATGGCGTACGTGTCGACCGCGACCGTCTCCTGGACCTGGGTGAAG
f6 CCTGGACCTGGGTGAAGAACTCAAGGAACAGGCAGAATCCCTCACGCGTCAAATCTACGA
f5 TCACGCGTCAAATCTACGAACTGGCGGGTACCGAATTCAACATTAACTCTCCGAAACAGC
f4 ACATTAACTCTCCGAAACAGCTCGCCGAGATTCTCTACGACAAACTGGGTCTGCCGGTTC
f3 CTGGGTCTGCCGGTTCTCAAAAAGACTAAAACGGGCTATTCTACCTCTGCGGACGTTCTG
f2 CCTCTGCGGACGTTCTGGAGAAACTGGCACCGCAACATGAAATCGTTGAAAAAATCCTGC
f1 GAAATCGTTGAAAAAATCCTGCACTACCGCCAAATCATGAAACTGATCTCCACCTATGTC
r1 TTTACCGGATTCCGGGTCGATTTCCTTCAGGAGGCCCTCGACATAGGTGGAGATCAGTTT
r2 GCGGCCAGTTGCAGTGATAGTCTGGTTGAAACGCGTGTGAATTTTACCGGATTCCGGGTC
r3 CAGGCGAATCGGGATATTTTGCAGGTTCGGCTCGGTAGAGCTGAGGCGGCCAGTTGCAGT
r4 CAGACGGAACGAATACCTGACGGATGCGACGACCTTCCTCCAGGCGAATCGGGATATTTT
r5 AATCTGAGAGTAATCTGCGCTCAGGATCTGCCAACCCGGTTCAGACGGAACGAATACCTG
r6 GAGACTCGTCGCCAGACAGATGAGCCAGTACGCGGAGCTCAATCTGAGAGTAATCTGCGC
r7 GTCTTAGTATGAATGTCCATGTCTTCGCTAAAAGCCTGTTTGAGAGACTCGTCGCCAGAC
r8 AACTTCATCTTCAGGGACACCGAACACATCCATAGCGGTCTTAGTATGAATGTCCATGTC
r9 CGAAATTAACCGCCTTTGCTTGACGACGCATGAGAGAGGTAACTTCATCTTCAGGGACAC
r10 GTTTTGGGACAGGCCGTAATCAGAAATGCCGTAGATGATACCGAAATTAACCGCCTTTGC
r11 AACGTTCAATGAATTGCGCCGCTACTTTACGTGGGATGTTGAGGTTTTGGGACAGGCCGT
r12 ACGATCCATGTATTCTTTAACACCAGGGTAAGATTGGAAGTAACGTTCAATGAATTGCGC
r13 TGGTAACGTAACCGTCTTTACGGGCTTGCTCTACAACACGATCCATGTATTCTTTAACAC
r14 AGCGAATTTCCGGGAGGTAGCGACGGCGGTTGAGCATGGTGGTAACGTAACCGTCTTTAC
r15 ATCGCCGTACGTTCCGCGAAAGTGCGGCGATTGTAGTTACGAGAGCGAATTTCCGGGAGG
r16 CGGTTTTGATAATATCTGCCGCAGAACCCTGGATCGGGGTGTTCATCGCCGTACGTTCCG
r17 CGCGGCGACGTTTGATCTCACGATGCAGGCGTACCATGGCGGTTTTGATAATATCTGCCG
r18 CAAAAATGAGTTCGTCGTGAACTTGGAGCAGCATACGAGACTTAACGCGGCGACGTTTGA
r19 CCAGATTTTTCATTTCTTCGAGTTCCTCTTCTGGAACTTCAAAAATGAGTTCGTCGTGAA
r20 ACGGAGAGCGGGACCGCTTGTTCCATAACCGTACGAACCAGATTTTTCATTTCTTCGAGT
r21 GCTTCATACCAAGTCTGACCGGTGTGGATATCAACTTTGAGCGGCACGGAGAGCGGGACC
r22 CTTCCTTTCGGGCTTTGTTAGCAGCCGGATCCTTATTTGGCTTCATACCAAGTCTGACC
Table 2: Oligonucleotides for the synthesis of paz
f4 TTTGTTTAACTTTAAGAAGGAGATATACATATGAGCCACCAGATCCGTTCTAAGAAAACCCTGTGGGAAC
f3 CTAAGAAAACCCTGTGGGAACTCGTTGGTCGTAATAAAGACGCGCTGCGTGATTTCCTGAAAGAACACCGTGGCA
f2 TGAAAGAACACCGTGGCACCATCCTGCTCCGTGACATCGCGTCTGAACACAAAGTTGTTTACAAACCGATCTTCA
f1 GTTGTTTACAAACCGATCTTCAAACGCTACAACGGTGACCCGGACCTGATCGAAGACAACTCTAACGACGTTGAA
r1 TTTTTTCAGTTCCGGGGTGTTCCAGTAACGTTCCAGGTGGTAGTCGTACCAGTGTTCAACGTCGTTAGAGTTGTC
r2 TTCGCCAGGATGATTGGTTGGTTCAGGTCAACCGGACCGAACTTTTTGTAGAACTCTTTTTTCAGTTCCGGGGTG
r3 ACAACGAACTGCGGCAGGAGGTGAACCAGGTCACCACGGTTGTGCTGACGCAGTGGTTTCGCCAGGATGATTGGT
r4 CTTCCTTTCGGGCTTTGTTAGCAGCCGGATCCTTAGTTATAAACCGGAACAACGAACTGCGGCABMC Biotechnology 2008, 8:44 http://www.biomedcentral.com/1472-6750/8/44
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cloning site as well as additional gene-specific primers
when needed. Both strands of each gene were sequenced.
Sequences were assembled and analyzed using the Staden
package version 1.6.0 [6].
Error correction
Sequencing errors were mended by in vivo homologous
recombination of overlapping plasmid fragments ampli-
fied by PCR. Oligonucleotide primers were 30–35 nucle-
otides long and were designed to include the correcting
nucleotide (when needed) at the midpoint. The reverse
primer of each overlapping fragment was the reverse-com-
plement of the forward primer of the next fragment (Fig-
ure 2). Each fragment was amplified in a 20 μl reaction
containing 2 μl (10×) PfuUltra II reaction buffer, 0.4 μl
(10 mM each) dNTP, 0.4 μl PfuUltra II fusion HS DNA
polymerase (Stratagene, La Jolla, CA, USA), 1 μl each
appropriate (10 μM) forward and reverse primer and a
variable amount of plasmid DNA template. The thermal
cycling conditions of the PCR were as follows: initial
denaturation at 95°C for 2 min; 25 cycles of 95°C for 20
s, 66–70°C for 20 s, 72°C for 90 s; final extension at 72°C
for 2 min. When indicated, PCR products of the expected
size were excised from a 0.8% agarose gel and purified
SeqTBIO method of PCR-based gene synthesis for paz and polA Figure 1
SeqTBIO method of PCR-based gene synthesis for paz and polA. The nucleotide sequences paz and polA were assem-
bled through a sequence of 4 and 22 reactions respectively and analyzed by agarose gel electrophoresis. Fragment sizes were 
compared against molecular markers ranging from 100 to 2000 bp. Two oligonucleotides were used for each amplification 
reaction starting with the central pair (f1 and r1), followed by the next pairs (f2 and r2, then f3 and r3, etc.) in the subsequent 
reactions, in an inside-out manner. The oligonucleotides overlapped by 15 to 23 nt. The entire paz sequence was synthesized 
in 4 reactions showing single products in each reaction with traces of unincorporated primers (A, lanes 1–4). The robustness 
of sequential step DNA assembly is shown for the synthesis of polA where single band fragments are clearly seen for each 
assembly step (B, lanes 1–22). Lane F shows the final synthesis product of polA. The assembled gene products for both proteins 
contained 30 nt of sequence at the 5'and 3' termini homologous to the terminal ends of a linearized plasmid vector of pET-3a 
for subsequent in vivo homologous recombination. These homologous regions (HR) were designed within the last outside 
primers sets used in the assembly process.
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using the QIAquick gel extraction kit (Qiagen, Valencia,
CA, USA) according to the manufacturer's instructions.
Unpurified PCR products were directly used for transfor-
mation without further manipulation. In both cases, 1 μl
of each product were mixed and used to transform com-
petent cells. Transformation, plasmid preparation and
sequencing were performed as described above.
Protein expression and purification
The two proteins were expressed and purified in exactly
the same way unless indicated otherwise. Expression plas-
mids containing the error-free inserts were directly trans-
formed into competent E. coli BL21(DE3). Competent
cells were prepared by the rubidium chloride method and
transformed with 10 ng of the recombinant plasmids as
described previously. Transformed cells were then mixed
with 150 μl LB medium, incubated 1 hour at 37°C/250
RPM and spread on LB-agar plates containing 100 mg/L
carbenicillin. Overnight colonies were then used to inoc-
ulate 20 mL LB cultures containing 100 mg/L carbenicillin
that were incubated for 8 hours at 37°C/250 RPM. The
resulting cultures were further distributed into 2 × 2 L of
LB medium containing the same type and amount of anti-
biotic. The cultures were allowed to grow at 37°C/250
RPM and the expression of the recombinant proteins was
induced by the addition of isopropyl thio-β-D-galactoside
Scheme of error correction using coupled methods of site directed mutagenesis and homologous recombination Figure 2
Scheme of error correction using coupled methods of site directed mutagenesis and homologous recombination. Assembled synthetic 
gene fragments subcloned into a plasmid vector are subjected initially to sequence analysis of the synthesized product to detect nucleotide errors. Error 
correction can be conducted in two ways using oligonucleotide primers (30–35 nucleotides long) that are designed to include the correcting nucleotide 
(when needed) at the midpoint. First, mutagenic primers are targeted exclusively against the assembled synthetic gene (route A). Two, three and four pairs 
of primers are required to correct one, two and three point mutation (ptm) sites respectively. DNA fragments are amplified by two or all primer pairs F1-
R1, F2-R2, F3-R3 and F1-R4 in separate reactions. The terminal primers have overlapping homologous regions with that of the targeted plasmid vector. 
Reaction products are mixed for transformation into an appropriate cell host. The second approach involves the amplification of the plasmid vector 
(routes B-D). To remove 3 point mutations, two correcting primers, reverse-complement of each other, are designed at each mutation site, with the cor-
recting nucleotide being at the midpoint of each primer. DNA fragments are amplified by PCR using primer pairs F1-R1, F2-R2 and F3-R3 respectively in 3 
separate reactions (D). Two pairs of primers are similarly used for 2 point mutations involving only 2 separate reactions (C). Single site error correction 
requires a non-mutagenic primer pair corresponding to a sequence in the vector backbone in addition to the correcting primer set such that 2 fragments 
are generated (as if 2 corrections were being made). Products of the correcting reactions are retransformed into competent cells for plasmid isolation and 
sequencing. Upon verification of error free clones, the plasmids are then transformed into an appropriate host cell for protein expression.
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(IPTG) at a final concentration of 0.5 mM when the opti-
cal density of the liquid culture at 600 nm reached 0.6.
After 6 hours, cells were harvested by centrifugation. All
subsequent steps were performed at 4°C. Cells were resus-
pended in buffer A (50 mM TRIS pH 7.5, 50 mM NaCl, 1
mM EDTA for PolA and 50 mM BIS-TRIS pH 6.5 50 mM
NaCl, 1 mM EDTA for PAZ) supplemented with 10 μg/mL
deoxyribonuclease I and ribonuclease I (New England
BioLabs, Ipswich, MA, USA) and disrupted by sonication
(6 cycles of 45 pulses) using a Branson Sonifier 250 (VWR
Scientific, West Chester, PA, USA). Cell debris were
removed by centrifugation (12000 g, 20 min). The super-
natant was heated for 30 min at 75°C and the precipitate
was removed by further centrifugation. The supernatant
was loaded into an ion exchange column (HiTrap Q
sepharose for PolA and HiTrap SP for PAZ) (Amersham,
USA) that had been pre-equilibrated with buffer A and
eluted with a 0.05–1 M NaCl linear gradient in buffer B,
using an Akta Explorer FPLC system (Amersham-Pharma-
cia, USA). Fractions containing the recombinant protein
(showing a band of the expected size on a SDS-PAGE gel)
were pooled, dialyzed against buffer A. The protein was
concentrated to 2 mL using a Amicon Ultra centrifugal fil-
ter device (Millipore, USA), applied to a Sephacryl S-200
gel filtration column (Pharmacia, USA) pre-equilibrated
with buffer A and eluted with the same buffer. Fractions
corresponding to the principal peak were collected,
pooled and concentrated for subsequent crystallization
screening. The final concentration were 15 and 22 mg/mL
for PolA and the PAZ domain respectively. Protein con-
centration was estimated using UV absorbance 280 nm
and 260 nm and determined by the Bradford assay [7]
using albumin as the protein standard.
Gel Electrophoresis
Synthesized DNA products were analyzed by agarose gel
electrophoresis as described by Sambrook & Russel [8].
Purified recombinant proteins were evaluated by SDS-
PAGE analysis according to the method of Laemmli [9]
using 12% polyacrylamide pre-cast gels (Invitrogen,
Carlsbad, CA, USA) in the presence of 0.1% SDS. SeeBlue
Plus2 Pre-stained standards (Invitrogen, Carlsbad, CA,
US) were use as standard protein markers in the range of
4–250 kDa.
Protein crystallization
Crystallization conditions for the purified proteins were
screened with Crystal Screen I and II crystallization screen-
ing reagents (Hampton Research, Aliso Viejo, CA, USA) by
sitting-drop vapor diffusion in IntelliPlates (Art Robbins,
Sunnyvale, CA, USA). The final diffraction quality crystals
were grown after approximately one week at room tem-
perature from optimal conditions based around the initial
conditions obtained from the commercial screen. The
conditions for their growth will be reported in a separate
publication with their structure determination.
X-ray data analysis
Protein crystals obtained were visually observed through
a polarized filter under a Nikon visible-light microscope
and photographed with a Kodak Digital Science DC120
camera. The crystals were carefully soaked for 2 min in a
cryopreservative solution containing 25% glycerol in pre-
cipitating reagent. Thereafter, the crystals were mounted
onto a 20 micron diameter nylon cryoloop (Hampton
Research, Aliso Viejo, CA) and directly flash frozen in liq-
uid nitrogen. The cryogenically preserved crystals were
mounted on a goniometer head cooled in a nitrogen
stream at 100 K using an MSC X-Stream Cryogenic Crystal
Cooler System (Molecular Structure Corporation, The
Woodlands, Texas, USA). Diffraction data were collected
using an MSC R-AXIS IV image plate detector with a crys-
tal-to-detector distance of 250 mm. The X-rays were gen-
erated by a Rigaku rotating anode generator operated at
50 kV and 100 mA and focused with MSC OSMIC confo-
cal mirrors. Images were collected at 1.0 degree oscillation
angles with an exposure time of 5 min. These data were
indexed using DENZO and reduced using SCALEPACK
within the HKL2000 program package [10].
Results
Gene synthesis
Several methods for assembling genes from synthetic oli-
gonucleotides have been developed [11-15]. Our effort to
include gene synthesis in a gene to structure pipeline for
non-automated structural genomics [16] prompted us to
expand current methods in gene assembly for recom-
binant protein production. Our method is a modification
on the thermodynamically balanced inside-out (TBIO)
PCR-based gene synthesis [12] and is referred to as
"Sequential TBIO (SeqTBIO)" because of the incremental
and individual successive steps involved. The principle is
illustrated in Figure 1. An initial DNA fragment made
from 2 central oligonucleotides is extended bidirection-
ally, one oligonucleotide pair at a time. Major differences
with the TBIO methods are the number of oligonucle-
otides per step (1 pair instead of 4 to 6), the number of
cycles per step (only 7 compared to 25) and the absence
of any gel purification step. Overall, despite a higher
number of steps, our method is faster and more robust
because the steps are simpler and require less manipula-
tion.
To demonstrate the simplicity of our improved methodol-
ogy for synthesizing DNA fragments of different sizes, the
assembly of two novel nucleotide sequences, paz and polA,
were performed. The protein encoded by paz is a 15.41
kDa PAZ (Piwi/Argonaute/Zwille) domain, a siRNA-bind-
ing domain of an Argonaute protein homologue. The polABMC Biotechnology 2008, 8:44 http://www.biomedcentral.com/1472-6750/8/44
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gene codes for a deletion mutant of a family A DNA
polymerase lacking the 5'-3' exonuclease domain, with a
molecular weight of 67.70 kDa. The paz  sequence was
assembled in just 4 steps (Figure 1A). Each reaction
resulted in a single band clearly showing an incremental
increase in DNA fragment size. The assembled synthetic
gene fragment contained a total of 449 base pairs and
included vector homologous regions at its ends. Two
clones were sequenced, one contained 2 point deletions
and the other one was error-free and was subsequently
used for protein expression.
Gene assembly results for polA are shown in Figure 1B.
Each reaction involving the synthesis of polA resulted in a
single band product. Because the yield began to decrease
after about 20 reactions (reactions 20–22), the last reac-
tion was repeated using more template (2 μl of the 21st
reaction product instead of 0.9) and more cycles (15
instead of 7), which was enough to obtain a pure single
DNA product (lane F). The assembled synthetic gene frag-
ment contained 1826 bp including sequences at the 5'and
3' termini that were homologous to the expression vector
sequence. After co-transformation with a linearized vector
and plasmid isolation from cultures grown from individ-
ual colonies, plasmids isolated from 4 clones were
sequenced. All contained the expected insert, and among
the 4 clones, a total of 6 single-nucleotide mutations were
detected, including 1 deletion, 3 transitions and 2 trans-
versions. A clone with a single mutation (the deletion)
was selected for error correction.
In vivo homologous recombination
We used in vivo homologous recombination to efficiently
insert assembly products into a propagating plasmid vec-
tor and to rapidly correct synthesis errors. Gene cloning
mediated by RecA-independent homologous recombina-
tion in E. coli is well documented [17-19] although it has
not become a mainstream technique despite its simplicity
and efficiency. It is based on the ability of many E. coli
strains (including the RecA deficient ones used in cloning)
to perform in vivo intermolecular recombination between
DNA fragments sharing homologous sequences at their
ends. In our experiments, synthetic gene fragments can be
quickly subcloned into a linearized target plasmid vector
(Figure 2) without restriction digest, ligation or other
enzymatic manipulation. Virtually 100% of the resulting
clones contained the correct insert, eliminating the need
for screening. In addition, synthetic DNA fragments pro-
duced with our method can be easily assembled further
into larger constructs by in vivo homologous recombina-
tion of overlapping fragments. We have successfully syn-
thesized a 3.6 kb and a 6 kb genes by assembling two 1.8
kb and three 2 kb fragments respectively (data not
shown).
Errror correction by Site Directed Mutagenesis
Synthetic genes inherently have errors derived mainly
from inaccuracies in the oligonucleotide syntheses and to
a lesser extent from the DNA polymerase-mediated assem-
bly [14]. The error rates observed in our assembly prod-
ucts were consistent with the 1 to 3 errors per kb reported
by others [20], and imply that, especially for larger genes,
prohibitively large numbers of sequencing reactions need
to be performed in order to have a high probability to find
a clone with the correct sequence [21]. Several approaches
have been proposed to decrease the error rate, in particu-
lar using enzymes involved in mismatch recognition on
renatured assembly products [20-22]. However, these
may be difficult to implement due to the cost and availa-
bility of such enzymes. Therefore, for small-scale gene
synthesis projects, it is often simpler to correct errors
through site-directed mutagenesis (SDM). Numerous
SDM techniques have been described over the last two
decades, many of which involve more than one PCR step,
the use of additional enzymes or further complex manip-
ulations [23,24]. We applied a SDM method based on in
vivo homologous recombination using a single PCR step,
which is both simple and efficient [18,25]. In its simplest
form, competent cells are directly transformed with PCR
products from a single amplification step generating over-
lapping fragments.
The error correction strategy using in vivo homologous
recombination is illustrated in Figure 2. We have
approached it in two ways. First, primers are designed to
produce corrected fragments of the gene assembly product
(Figure 2A). In this case, two, three and four pairs of prim-
ers (F1-R1, F2-R2, F3-R3 and F4-R4) are required to cor-
rect one, two and three error sites respectively in separate
reactions. The resulting PCR products are mixed with the
linearized plasmid vector and used to transform compe-
tent cells in which in vivo homologous recombination is
allowed to occur. In our hands, as many as 4 PCR ampli-
fied corrected fragments recombined accurately with the
recipient vector and generated error corrected products.
The second approach involves the amplification of DNA
fragments that include the plasmid vector (Figure 2, pan-
els B-D). Typically, up to 3 point mutations are corrected
at one time. In such a case, two correcting primers,
reverse-complement of each other, are designed at each
mutation site, with the correcting nucleotide being at the
center of each primer. DNA fragments are amplified by
PCR using primer pairs F1-R1, F2-R2 and F3-R3 respec-
tively in 3 separate reactions. In the case of 2 point muta-
tions, two pairs of primers are similarly used such that
there will be only 2 separate reactions. When a single syn-
thesis error needs to be corrected, a non-mutagenic primer
set corresponding to a sequence in the vector backbone is
used in addition to the correcting primer set such that 2BMC Biotechnology 2008, 8:44 http://www.biomedcentral.com/1472-6750/8/44
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fragments are generated (as if 2 corrections were being
made) in order to avoid using mutually annealing primers
in a single reaction.
In correcting the gene synthesis error of polA that had a
point deletion, the two strategies were pursued in parallel.
First, 2 overlapping fragments of the same plasmid were
amplified (illustrated in Figure 2, panel B), each with a
primer correcting the deletion and a primer correspond-
ing to a sequence in the vector backbone. The primers in
each fragment were reverse complement of the primers in
the other fragment. In the second approach, only the gene
synthesis product was amplified from the plasmid tem-
plate in 2 fragments (each fragment being amplified with
a correcting primer and a terminal oligonucleotide used
for the original gene synthesis). In this case, the amplifica-
tion products were mixed with the linearized vector allow-
ing  in vivo recombination to occur between the 3
fragments (illustrated in Figure 2, panel A). In both cases,
40 pg/μl of plasmid template was used in the correcting
PCR mixture. Between 10 and 100 colonies were obtained
for each transformation.
A random selection of colonies was analyzed for success-
ful recombinant inserts. In both correction procedures
used, the correction efficiency was 50% in which half the
clones analyzed contained completely accurate sequences
of the recombinant insert. A corrected clone from the first
approach was selected for protein expression to demon-
strate the integrity of the plasmid in the face of possible
site mutations in the vector sequence.
An obvious concern when plasmids are used as PCR tem-
plates is the risk that they compete with the desired
recombination products after transformation. Even if
amplified linear DNA is several orders of magnitude more
concentrated than the circular plasmid template in the
PCR products, homologous recombination being a rare
event, even a modest amount of circular plasmid template
may result in the unwanted presence of non-recombined
clones among the colonies after transformation. Several
strategies have been proposed to address this problem,
including gel purification of the amplified DNA fragment,
linearization of the plasmid template by restriction
enzyme digestion prior to PCR [18] and treatment of PCR
products with DpnI which cleaves methylated DNA [26].
In our effort to minimize the number of steps and to sim-
plify the method, we attempted to prevent plasmid carry-
over by diluting the plasmid template in the correcting
PCR. In the case of polA, this strategy succeeded but the
dilution level was not optimal since only half of the
clones were recombination products.
When applying the same error correction technique to
other genes, we found that further diluting the template to
3 pg/μl or less in the correcting PCR consistently resulted
in 100% correction efficiency, effectively decreasing tem-
plate carry-over to negligible levels. However, there were
unexpected consequences as new mutations appeared in
otherwise corrected clones. Despite using one of the high-
est-fidelity DNA polymerases commercially available,
unintended mutations appeared when plasmid templates
were diluted to 10 pg/μl or less. The mutation rate seemed
to correlate with the level of template dilution, with over
1 mutation per kb when the template concentration was
under 1 pg/μl. All new mutations involved a single nucle-
otide. A compilation of 79 mutations detected after
sequencing 94 kb of corrected clones showed transitions
to be prevalent (59% of all mutations observed) with an
equal amount of type 1 (A to G and T to C), and type 2 (G
to A and C to T), followed by deletions (28%), transver-
sions (9%) and insertions (4%). Note that in all cases
where new mutations were observed the template concen-
tration was significantly lower than the DNA polymerase
manufacturer's recommended 100 to 600 pg/μl of plas-
mid template input. In order to obtain reproducible
100% error correction while avoiding additional muta-
tions, we found it necessary to limit the template dilution
in the correcting PCR to the levels recommended by the
enzyme's manufacturer and therefore to include a tem-
plate removal step before transformation.
Our observations of increased mutation rates when using
highly diluted templates in PCR are consistent with a pre-
vious report that low copy number template can decrease
the fidelity of both Taq and Pfu DNA polymerases [27]. To
our knowledge, no explanation was ever proposed to
account for such a phenomenon. However, it can have
serious implications for PCR methods involving samples
with limited availability such as ancient DNA, forensics or
pre-implantation genetic diagnosis. Further studies are
needed to confirm whether this phenomenon affects PCR
in general and how the sensitivity to template concentra-
tion varies among different DNA polymerases or with var-
ying reaction conditions.
Protein expression, crystallization and preliminary X-ray 
analysis
Expression of recombinant proteins PAZ and PolA were
performed by transforming an E. coli expression cell strain
with the plasmids containing the error-free inserts. A ran-
dom selection of resulting colonies was screened for small
scale expression. Clones that demonstrated recombinant
expression as determined by SDS-PAGE analysis were fur-
ther cultured for large scale preparation. The yields of
both proteins were approximately 30 mg/L. Since both
PAZ and PolA recombinant proteins were derived from
hyperthermophilic microorganisms, they had the out-
standing property of being heat resistant. Thus, the pro-
teins can be immediately purified to more than 70% afterBMC Biotechnology 2008, 8:44 http://www.biomedcentral.com/1472-6750/8/44
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a heat selection step. PAZ and PolA can be purified to
more than 90% homogeneity based on SDS-PAGE analy-
sis after ion exchange and size exclusion chromatography
(Figure 3). The approximate size of the purified proteins
were 15 kDa and 70 kDa for PAZ and PolA respectively. In
both cases, protein crystals suitable for X-ray diffraction
were obtained within 5 days, and as a result their space
group and unit parameters were determined. PAZ crystals
appeared as orthorhombic habit and grew as large as 0.5
mm in the longest dimension. The space group of the crys-
tals was determined to be P212121 with unit cell dimen-
sions of a = 36.831 Å, b = 58.671 Å and c = 61.819 Å.
Prismatic crystals of PolA grew as big as 0.4 mm in the
longest dimension. The space group and unit cell dimen-
sions were identified to be P3221 and a = b = 148.07 Å, c
= 105.63 Å respectively. The crystals of PAZ and PolA dif-
fracted in the range between 2.5–8 Å resolution using a
home laboratory X-ray source. The crystallographic struc-
ture determination of both proteins is in progress.
Discussion
The approach to DNA synthesis described here was specif-
ically designed for rapidly assembling DNA coding
regions for crystallizing recombinant proteins. The
sequential method, seqTBIO, builds one pair of oligonu-
cleotide fragments at a time by PCR-based gene synthesis
resulting in reliable and consistent DNA assembly for
almost any sequence. In standard PCR-based gene synthe-
sis, 4–6 primer pairs are used for amplification at a time.
Thus in most cases secondary products are easily pro-
duced from non-specific amplification requiring purifica-
tion after each assembly cycle. The integrity of the gene
synthesis also cannot be readily monitored after an assem-
bly of each oligonucleotide set with batch PCR-based syn-
SDS-PAGE analysis and crystallization of PAZ and PolA Figure 3
SDS-PAGE analysis and crystallization of PAZ and PolA. Purified recombinant proteins PAZ and PolA are shown in 
the upper panels (lanes 2) against standard molecular markers (lanes 1) containing myosin, phosphorylase, BSA, glutamic dehy-
drogenase, alcohol dehydrogenase, carbonic anhydrase, myoglobin red, lysozyme, aprotinin and insulin B chain on a 11% poly-
acrylamide gel. Approximately 15 μg of purified protein was loaded in each gel (lanes 2) and visualized with Coomassie brilliant 
blue. The arrows indicate recombinant proteins at about 15 kDa and 70 kDa for PAZ and PolA respectively. The proteins 
were estimated to be more than 90% homogeneous. Crystals of PAZ and PolA are shown in the bottom panels along with 
their corresponding space group and unit cell parameters as determined by preliminary X-ray analysis.
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thesis protocols. We have compared the synthesis of polA,
along with other genes not reported here using estab-
lished PCR-based gene synthesis procedures
[12,15,28,29]. The resulting gene assemblies were prob-
lematic (Figure 4) requiring extensive optimization of the
PCR conditions in each step. This is particularly true for
larger gene fragments (greater than 1 kb). The reactions
often produced non-specific or multiple gene products as
revealed by numerous or smeared bands in gel electro-
phoresis analysis. Even though our approach is not guar-
anteed to be fail-safe, it has shown to have great
consistency in the continuous synthesis of homogeneous
DNA products for different types of gene sequences
throughout the assembly steps.
Error corrections have been the limiting factor to complet-
ing accurate gene synthesis. We have corrected sequence
errors using site-directed mutagenesis coupled with
homologous recombination [18,25] because of its sim-
plicity and efficiency. Two tactics have been considered
and both offer high-speed repair and subcloning inde-
pendent of restriction site availability and ligation reac-
tions. One method involves the amplification of an entire
circular plasmid by PCR using mutagenic primers with
overlapping sequences, while the other approach utilizes
PCR amplification with mutagenic primers against the
assembled synthetic gene fragment only. Even though we
have demonstrated successful protein expression with cor-
rected constructs using the former, we have observed
higher success in subsequent protein expression trials
with the latter approach. This is because the full-length
amplification of the plasmid can give rise to second-site
mutations in the vector sequence. Consequently, the
expression plasmid may be rendered dysfunctional in rep-
lication, transcription or translation diminishing the
occurrence of transformed cells that would be able to
overexpress the targeted gene product. However, most of
the time, the error corrected inserts can be subcloned into
another vector. In the case of correcting errors by using
mutagenic primers to amplify the assembled synthetic
gene fragment only, there is minimal concern in altering
the expression vector sequence since no part of the plas-
mid is amplified. As a result, the plasmid can be used for
protein expression with increased confidence that possi-
ble failure does not result from alterations in the vector
sequence.
Coupling a more reliable DNA synthesis approach with
an efficient means of error corrections without any addi-
tional purification or enzymatic requirements provides a
rapid means to clone and express proteins when the
source of genomic or complementary DNA is limited or
not available at all. This is particularly useful in crystallo-
graphic studies where altering specific amino acid sites or
regions is required for overexpression or structural pack-
ing. Protein crystallization is often very sensitive to inter-
and intramolecular packing where, for example, produc-
ing optimal ionic network interfaces through the apposi-
tion of extensive hydrophobic surfaces [30] or even
constructing protein chimeras determine the successful
outcome of a crystallographic structure [31]. In addition,
strategic incorporation of sulphur [32,33] containing res-
idues or methionine for selenomethionine replacement
would be very useful in constructing protein molecules
with intrinsic atoms useful for crystallographic phasing
(i.e. single-wavelength-anomalous diffraction) [34].
It is very feasible to integrate gene synthesis into a non-
automated gene to crystal pipeline such that genes can be
systematically designed, synthesized and implemented
Comparative gene synthesis of polA coding region by meth- ods of TBIO and SeqTBIO Figure 4
Comparative gene synthesis of polA coding region by 
methods of TBIO and SeqTBIO. The oligonucleotide 
pairs f1-r1, f2-r2, f3-r3 and f4-r4 were used to attempt the syn-
thesis of a 351 bp central fragment of the polA coding region. 
The initial TBIO gene synthesis included the mixture of 8 
primers and the reaction was subjected to 30 cycles of PCR 
amplification (lane 2). An early version of the SeqTBIO 
approach was performed in parallel (lanes 3–6) using the first 
3 oligonucleotide pairs only. The central pair (f1-r1) was ini-
tially assembled (lane 3) followed by next pairs f2-r2 (lane 4, 
5) and f3-r3 (lane 6). The TBIO reaction produced a smear 
and did not seem to generate a unique fragment but instead a 
range of product sizes ranging from 190 bp – 600 bp. In con-
trast, each SeqTBIO reaction generated a single-band prod-
uct of the expected size. A PCR negative control is shown in 
lane 1. The reaction products were analyzed by electro-
phoresis on a 1.2% agarose gel stained with ethidium bro-
mide and visualized by UV illumination.
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for recombinant expression followed by crystallization
screening in a efficient throughput manner. Figure 5 illus-
trates the flow of execution from design to crystal. Once
the sequence of the open reading frame has been decided,
the process from ordering the oligonucleotides to crystal-
lization screens can be realized within 2 weeks. One of the
most time consuming steps found in structural genomics
pipelines at the level of protein expression is subcloning
the amplified products into appropriate expression vec-
tors by restriction digest and ligation reactions followed
by transformation into a propagating host [16]. We have
reported directional cloning methods that use in vivo
homologous recombination to be the most efficient and
cost effective because cloning can be accomplished with-
out purchasing special vectors or expensive enzymes. The
procedure can be achieved rapidly using multichannel
pipettes to dispense multiple reactions and bulk transfor-
mation in competent cells. We have routinely obtained
over 95% success in recombinant insertion of the synthe-
sized or modified gene fragments. We have been using the
pET vectors (Novagen, Madison, WI, USA) for successful
expression of hyperthermophilic proteins. No tagging was
necessary since a heat selection step was included as part
of the initial purification procedure and used as an indica-
tor for thermal stability and solubility. In high throughput
mode, it is possible to examine multiple synthesis prod-
ucts and undergo expression trials in 96-well plates as
reviewed by Hughes and Ng [16].
The paz and polA genes are shown here as examples on
how we have used the gene synthesis technique to pro-
duce novel proteins for protein crystallization. When the
natural coding sequences of both proteins were cloned
and prepared for recombinant protein expression in E.
coli, all attempts to produce proteins failed. Both
sequences showed codon usage that significantly diverged
from that of E. coli. Recombinant expression could only be
obtained after codons were optimized.
In our pipeline, large scale expression routinely involves
two chromatographic steps executed after an initial heat
selection. This includes separation by ion exchange and
size exclusion chromatography and the proteins are usu-
ally screened immediately for crystallization. In the case
Gene to crystal flowchart Figure 5
Gene to crystal flowchart. Gene synthesis can be integrated into an experimental pipeline where proteins can be designed 
for crystallization screening. It is possible to design variations of protein constructs by exploiting the SeqTBIO method of 
sequential DNA assembly (path 1 to 6). Different constructs can be screened for expression in 96-well format array and evalu-
ated for the protein solubility and stability (path 7). In our case, we used heat stability as a biochemical selection criterion. 
However, recombinant tags can be easily incorporated at the DNA synthesis level whereby the resulting expressed proteins 
can be selected with affinity binding matrices (e.g. His or GST tags). Large scale production can then be performed for crystal-
lization trials (path 8–9). Initial crystals obtained would undergo optimization and preliminary X-ray analysis (path 10). Further 
protein sequence changes can be made if necessary for further processing (path 11).
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of PAZ and PolA, crystals were obtained in the initial
screening conditions and subjected to preliminary X-ray
analysis. General crystallization conditions can be opti-
mized in many ways and have been discussed previously
[16,35,36]. If proteins crystallize poorly or not at all after
exhaustive searches in crystallization conditions, then
changing the protein molecule itself would be reasonable.
Molecular changes can be made quite readily at the syn-
thesis level where strategic amino acid residues or
domains can be rearranged at will to optimize molecular
packing. One interesting possibility, although untried, is
to attempt expressing the proteins in incremental frag-
ments that corresponds to the inside-out direction of syn-
thesis of the recombinant open reading frame. Since gene
synthesis can be incremental, each assembly cycle can be
subcloned and tried for protein expression and crystalliza-
tion. This possible approach would be of great interest in
examining the truncation effects of the N- and C-termini
of a protein on molecular stability, packing and ultimately
crystallization. Other variations can involve domain
switching or elimination and symmetry imposition. There
are obviously countless other possibilities by which incre-
mental changes of protein fragments may give rise to
novel assemblies. The gene synthesis technique reported
here integrates well into a gene to crystal pipeline, and its
approach is applicable to small structural genomics
projects as well as protein engineering studies.
Conclusion
The SeqTBIO method of gene synthesis, associated with in
vivo  homologous recombination-mediated cloning and
error correction, was shown to integrate well in a gene to
structure pipeline. As illustrated by the examples of the paz
and polA genes, gene assembly was simple, efficient, and
did not require any specific reagent or enzyme other than
those used in PCR, nor any complex manipulation. Clon-
ing and error correction were straightforward, requiring
nothing more than transforming competent cells with
amplified gene fragments. The described methodology to
generate cloned genes of any sequence for protein expres-
sion and further structural studies does not require any
expensive equipment or particular technical skill and can
therefore benefit laboratories with limited resources.
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